News
Qurgen real-time updates on corporate news, industry trends and exciting events, witnessing every step of growth.
News
Qurgen initiated a multicenter phase I clinical trial of SON-DP in the United States for the treatment of solid tumors including, breast, ovarian, pancreatic, and colorectal cancers. The trial is being conducted across the following clinical sites.